Receptor interacting protein-2 contributes to host defense against Anaplasma phagocytophilum infection.
暂无分享,去创建一个
B. Sukumaran | E. Fikrig | R. Flavell | Y. Ogura | Koichi S. Kobayashi | João H. F. Pedra | Koichi S. Kobayashi
[1] S. Winter,et al. A Salmonella Virulence Factor Activates the NOD1/NOD2 Signaling Pathway , 2011, mBio.
[2] S. Batra,et al. Receptor-Interacting Protein 2 Controls Pulmonary Host Defense to Escherichia coli Infection via the Regulation of Interleukin-17A , 2011, Infection and Immunity.
[3] D. Philpott,et al. Essential role of Rip2 in the modulation of innate and adaptive immunity triggered by Nod1 and Nod2 ligands , 2011, European journal of immunology.
[4] Grace Y Chen,et al. Sterile inflammation: sensing and reacting to damage , 2010, Nature Reviews Immunology.
[5] Y. Rikihisa,et al. Microreview: Type IV secretion in the obligatory intracellular bacterium Anaplasma phagocytophilum , 2010, Cellular microbiology.
[6] R. Flavell,et al. Cooperation between Multiple Microbial Pattern Recognition Systems Is Important for Host Protection against the Intracellular Pathogen Legionella pneumophila , 2010, Infection and Immunity.
[7] S. Akira,et al. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses , 2009, Nature.
[8] D. Underhill,et al. The NOD/RIP2 Pathway Is Essential for Host Defenses Against Chlamydophila pneumoniae Lung Infection , 2009, PLoS pathogens.
[9] N. Warner,et al. Function of Nod‐like receptors in microbial recognition and host defense , 2009, Immunological reviews.
[10] C. Bogdan,et al. The elimination of Anaplasma phagocytophilum requires CD4+ T cells, but is independent of Th1 cytokines and a wide spectrum of effector mechanisms , 2008, European journal of immunology.
[11] D. Philpott,et al. The microbial and danger signals that activate Nod-like receptors. , 2008, Cytokine.
[12] Kerry R. Buchholz,et al. The Cytosolic Pattern Recognition Receptor NOD1 Induces Inflammatory Interleukin-8 during Chlamydia trachomatis Infection , 2008, Infection and Immunity.
[13] J. Tschopp,et al. The inflammasome: a danger sensing complex triggering innate immunity. , 2007, Current opinion in immunology.
[14] E. Fikrig,et al. c-Jun NH2-Terminal Kinase 2 Inhibits Gamma Interferon Production during Anaplasma phagocytophilum Infection , 2007, Infection and Immunity.
[15] Ruth R. Montgomery,et al. ASC/PYCARD and Caspase-1 Regulate the IL-18/IFN-γ Axis during Anaplasma phagocytophilum Infection1 , 2007, The Journal of Immunology.
[16] B. Sukumaran,et al. IL-12/23p40-dependent clearance of Anaplasma phagocytophilum in the murine model of human anaplasmosis. , 2007, FEMS immunology and medical microbiology.
[17] J. Bertin,et al. MDP‐induced interleukin‐1β processing requires Nod2 and CIAS1/NALP3 , 2007, Journal of leukocyte biology.
[18] J. Dumler,et al. Differential Innate Immune Cell Activation and Proinflammatory Response in Anaplasma phagocytophilum Infection , 2007, Infection and Immunity.
[19] Kerry R. Buchholz,et al. Activation of the host cell proinflammatory interleukin‐8 response by Chlamydia trachomatis , 2006, Cellular microbiology.
[20] D. Guttridge,et al. ASC Directs NF-κB Activation by Regulating Receptor Interacting Protein-2 (RIP2) Caspase-1 Interactions1 , 2006, The Journal of Immunology.
[21] Jonathan Crabtree,et al. Comparative Genomics of Emerging Human Ehrlichiosis Agents , 2006, PLoS genetics.
[22] B. Sukumaran,et al. Early Transcriptional Response of Human Neutrophils to Anaplasma phagocytophilum Infection , 2005, Infection and Immunity.
[23] J. Bakken,et al. Human Granulocytic Anaplasmosis and Anaplasma phagocytophilum , 2005, Emerging infectious diseases.
[24] Richard A. Flavell,et al. Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract , 2005, Science.
[25] E. Fikrig,et al. Interferon-γ deficiency reveals that 129Sv mice are inherently more susceptible to Anaplasma phagocytophilum than C57BL/6 mice , 2004 .
[26] E. Fikrig,et al. CXCR2 Blockade Influences Anaplasma phagocytophilum Propagation but Not Histopathology in the Mouse Model of Human Granulocytic Anaplasmosis , 2004, Clinical Diagnostic Laboratory Immunology.
[27] E. Fikrig,et al. Anaplasma phagocytophilum Utilizes Multiple Host Evasion Mechanisms To Thwart NADPH Oxidase-Mediated Killing during Neutrophil Infection , 2004, Infection and Immunity.
[28] J. Dumler,et al. Frontline: Control of Anaplasma phagocytophilum, an obligate intracellular pathogen, in the absence of inducible nitric oxide synthase, phagocyte NADPH oxidase, tumor necrosis factor, Toll‐like receptor (TLR)2 and TLR4, or the TLR adaptor molecule MyD88 , 2004, European journal of immunology.
[29] E. Fikrig,et al. Interferon-gamma deficiency reveals that 129Sv mice are inherently more susceptible to Anaplasma phagocytophilum than C57BL/6 mice. , 2004, FEMS Immunology & Medical Microbiology.
[30] E. Fikrig,et al. Invasion and survival strategies of Anaplasma phagocytophilum , 2003, Cellular microbiology.
[31] S. Barthold,et al. The mouse as a model for investigation of human granulocytic ehrlichiosis: current knowledge and future directions. , 2002, Comparative medicine.
[32] C. Janeway,et al. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems , 2002, Nature.
[33] G. Cheng,et al. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses , 2002, Nature.
[34] S. Malawista,et al. Exploitation of Interleukin-8-Induced Neutrophil Chemotaxis by the Agent of Human Granulocytic Ehrlichiosis , 2001, Infection and Immunity.
[35] J. Bakken,et al. Human granulocytic ehrlichiosis. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[36] E. Fikrig,et al. Granulocytic Ehrlichiosis in Mice Deficient in Phagocyte Oxidase or Inducible Nitric Oxide Synthase , 2000, Infection and Immunity.
[37] E. Fikrig,et al. Gamma Interferon Dominates the Murine Cytokine Response to the Agent of Human Granulocytic Ehrlichiosis and Helps To Control the Degree of Early Rickettsemia , 2000, Infection and Immunity.
[38] J. Bakken,et al. Serum Cytokine Responses during Acute Human Granulocytic Ehrlichiosis , 2000, Clinical Diagnostic Laboratory Immunology.
[39] J. Dumler,et al. Pathology, immunohistology, and cytokine responses in early phases of human granulocytic ehrlichiosis in a murine model. , 2000, The Journal of infectious diseases.
[40] H. Lepidi,et al. Comparative pathology, and immunohistology associated with clinical illness after Ehrlichia phagocytophila-group infections. , 2000, The American journal of tropical medicine and hygiene.
[41] J. Dumler,et al. Development and distribution of pathologic lesions are related to immune status and tissue deposition of human granulocytic ehrlichiosis agent-infected cells in a murine model system. , 1999, The Journal of infectious diseases.
[42] E. Fikrig,et al. Granulocytic ehrlichiosis in the laboratory mouse. , 1998, The Journal of infectious diseases.
[43] E. Fikrig,et al. Immunization against the agent of human granulocytic ehrlichiosis in a murine model. , 1997, The Journal of clinical investigation.
[44] J. Dawson,et al. Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle. , 1996, Proceedings of the National Academy of Sciences of the United States of America.